John-Michel Huss Insider Profile
4 Followers
John-Michel Huss, former Senior Officer at Theratechnologies, holds 82.56K shares in ADVANZ PHARMA (Ticker: CXRXF), holds 14.00K shares in Theratechnologies (Ticker: THTX). Most recently, John-Michel Huss Sold ― shares of ADVANZ PHARMA on Jun 24, 2015 for an estimated value of $703.86K.
John-Michel Huss's Trading History
| CXRXFADVANZ PHARMA | Jun 24, 2015 | ― | Informative Sell | 703.86K | $1.41M | |
| THTXTheratechnologies | Jan 09, 2012 | ― | Informative Buy | 9.96K | $47.46K |
You May Also Like
John-Michel Huss insider profile FAQ
What is the percentage of profitable transactions made by John-Michel Huss?
The percentage of profitable transactions made by John-Michel Huss is 100%.
What is the average return per transaction made by John-Michel Huss?
The average return per transaction made by John-Michel Huss is 69.60%.
What stocks does John-Michel Huss hold?
John-Michel Huss holds: THTX, CXRXF stocks.
What was John-Michel Huss’s latest transaction?
John-Michel Huss’s latest transaction was an Informative Sell of $703.86K.
What was John-Michel Huss's most profitable transaction?
John-Michel Huss’s most profitable transaction was an Informative Sell of CXRXF stock on June 24, 2015. The return on the trade was 71.10%.
What is John-Michel Huss's role in Theratechnologies?
John-Michel Huss's role in Theratechnologies is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
